Investor
Also: RDMD locks in $14M for rare disease therapy research; VIDA Diagnostics raises $11M for AI lunch imaging analysis.
Alongside the purchase of Amblyotech, the pharma company announced upcoming collaborations with major video game publisher Ubisoft and McGill University.
pandemic
In this COVID-19 era, the need for health and care systems to become agile and change is very real.
The new tool will be combined with Biofourmis' Biovitals platform and be able to give insights to cancer patients at home.
Also: Mercom's Q1 2020 digital health funding report; Fitbit, Scripps, Stanford collaborate on COVID-19 detection research.
Many are anticipating greater adoption of digital health services and more favorable regulatory and reimbursement environments, according to a recent poll sampling 513 digital health and adjacent companies.
Also: Datos Health ties off $7 million in Series A funding; Wellthy Therapeutics collects $4 million in pre-Series A; Lifesprk fleshes out tech with $16.1 million.
Amid COVID-19, a new 1,000-person survey suggests high demand for remote health services.
The company plans to use the new funds to expand commercialization in the US, Europe and Israel.